Compliance
China Blockchain Anti-Counterfeiting Policy Review: What It Means for Luxury in China
China Blockchain Anti-Counterfeiting Policy Review: What It Means for Luxury in China As of early 2025, China's State Administration for Market Regula
Compliance
China Anti-Unfair Competition Law Review: What It Means for Luxury Brands in China
China Anti-Unfair Competition Law Review: What It Means for Luxury Brands in China The 2023 review of China's Anti-Unfair Competition Law (反不正当竞争法, An
Compliance
What are the counterfeit risks for luxury brands in China?
Counterfeit Risks for Luxury Brands in China: An FAQ Counterfeit goods cost luxury brands an estimated USD 30 billion annually in China, representing
Compliance
China Brand Protection Update: New IP Enforcement Rules — Key Takeaways
China Brand Protection Update: New IP Enforcement Rules — Key Takeaways for Consumer Electronics China’s State Administration for Market Regulation (S
Compliance
China Pharma Update: Patent Linkage System Launches in 2026 — Key Takeaways
China Patent Linkage System: 2026 National Rollout — 5 Key Takeaways for Foreign Pharma China's national 专利链接制度 (Patent Linkage System, zhuānlì liànji
China Blockchain Anti-Counterfeiting Policy Review: What It Means for Luxury in China
China Blockchain Anti-Counterfeiting Policy Review: What It Means for Luxury in China As of early 2025, China's State Administration for Market Regula
China Anti-Unfair Competition Law Review: What It Means for Luxury Brands in China
China Anti-Unfair Competition Law Review: What It Means for Luxury Brands in China The 2023 review of China's Anti-Unfair Competition Law (反不正当竞争法, An
What are the counterfeit risks for luxury brands in China?
Counterfeit Risks for Luxury Brands in China: An FAQ Counterfeit goods cost luxury brands an estimated USD 30 billion annually in China, representing
China Brand Protection Update: New IP Enforcement Rules — Key Takeaways
China Brand Protection Update: New IP Enforcement Rules — Key Takeaways for Consumer Electronics China’s State Administration for Market Regulation (S
China Pharma Update: Patent Linkage System Launches in 2026 — Key Takeaways
China Patent Linkage System: 2026 National Rollout — 5 Key Takeaways for Foreign Pharma China's national 专利链接制度 (Patent Linkage System, zhuānlì liànji
How Novartis Protected IP in China: Patent Strategy Case Study
How Novartis Protected IP in China: Patent Strategy Case Study How Novartis Protected IP in China: Patent Strategy Case Study Intellectual property pr
